nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—bone cancer	0.864	1	CbGaD
Brinzolamide—Dorzolamide—CYP3A4—bone cancer	0.00647	1	CrCbGaD
Brinzolamide—Pain in extremity—Epirubicin—bone cancer	0.000506	0.00389	CcSEcCtD
Brinzolamide—Myalgia—Cisplatin—bone cancer	0.000505	0.00389	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000501	0.00386	CcSEcCtD
Brinzolamide—Liver function test abnormal—Methotrexate—bone cancer	0.000499	0.00384	CcSEcCtD
Brinzolamide—Discomfort—Cisplatin—bone cancer	0.000499	0.00384	CcSEcCtD
Brinzolamide—Breast disorder—Methotrexate—bone cancer	0.000488	0.00376	CcSEcCtD
Brinzolamide—Infection—Cisplatin—bone cancer	0.000481	0.0037	CcSEcCtD
Brinzolamide—Nervous system disorder—Cisplatin—bone cancer	0.000475	0.00365	CcSEcCtD
Brinzolamide—Tachycardia—Cisplatin—bone cancer	0.000472	0.00364	CcSEcCtD
Brinzolamide—Skin disorder—Cisplatin—bone cancer	0.00047	0.00362	CcSEcCtD
Brinzolamide—Pain in extremity—Doxorubicin—bone cancer	0.000468	0.0036	CcSEcCtD
Brinzolamide—Diplopia—Doxorubicin—bone cancer	0.000468	0.0036	CcSEcCtD
Brinzolamide—Asthma—Methotrexate—bone cancer	0.000467	0.0036	CcSEcCtD
Brinzolamide—Liver function test abnormal—Epirubicin—bone cancer	0.000467	0.0036	CcSEcCtD
Brinzolamide—Abdominal pain upper—Epirubicin—bone cancer	0.000462	0.00356	CcSEcCtD
Brinzolamide—Breast disorder—Epirubicin—bone cancer	0.000457	0.00352	CcSEcCtD
Brinzolamide—Hypotension—Cisplatin—bone cancer	0.000452	0.00348	CcSEcCtD
Brinzolamide—Nasopharyngitis—Epirubicin—bone cancer	0.000452	0.00348	CcSEcCtD
Brinzolamide—Abdominal discomfort—Methotrexate—bone cancer	0.000448	0.00345	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000441	0.0034	CcSEcCtD
Brinzolamide—Asthma—Epirubicin—bone cancer	0.000437	0.00337	CcSEcCtD
Brinzolamide—Paraesthesia—Cisplatin—bone cancer	0.000435	0.00335	CcSEcCtD
Brinzolamide—Liver function test abnormal—Doxorubicin—bone cancer	0.000432	0.00333	CcSEcCtD
Brinzolamide—Dyspnoea—Cisplatin—bone cancer	0.000431	0.00332	CcSEcCtD
Brinzolamide—Erectile dysfunction—Methotrexate—bone cancer	0.00043	0.00331	CcSEcCtD
Brinzolamide—Abdominal pain upper—Doxorubicin—bone cancer	0.000427	0.00329	CcSEcCtD
Brinzolamide—Angina pectoris—Epirubicin—bone cancer	0.000426	0.00328	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—bone cancer	0.000423	0.00326	CcSEcCtD
Brinzolamide—Decreased appetite—Cisplatin—bone cancer	0.000421	0.00324	CcSEcCtD
Brinzolamide—Bronchitis—Epirubicin—bone cancer	0.00042	0.00324	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—bone cancer	0.000418	0.00322	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Cisplatin—bone cancer	0.000418	0.00322	CcSEcCtD
Brinzolamide—Infestation NOS—Methotrexate—bone cancer	0.000416	0.00321	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—bone cancer	0.000416	0.00321	CcSEcCtD
Brinzolamide—Depression—Methotrexate—bone cancer	0.000415	0.0032	CcSEcCtD
Brinzolamide—Pain—Cisplatin—bone cancer	0.000414	0.00319	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—bone cancer	0.000405	0.00312	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—bone cancer	0.000404	0.00311	CcSEcCtD
Brinzolamide—Pollakiuria—Epirubicin—bone cancer	0.000404	0.00311	CcSEcCtD
Brinzolamide—Feeling abnormal—Cisplatin—bone cancer	0.000399	0.00307	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—bone cancer	0.000394	0.00303	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—bone cancer	0.000394	0.00303	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—bone cancer	0.000393	0.00302	CcSEcCtD
Brinzolamide—Infestation NOS—Epirubicin—bone cancer	0.00039	0.003	CcSEcCtD
Brinzolamide—Infestation—Epirubicin—bone cancer	0.00039	0.003	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—bone cancer	0.000389	0.00299	CcSEcCtD
Brinzolamide—Conjunctivitis—Epirubicin—bone cancer	0.000379	0.00292	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—bone cancer	0.000374	0.00288	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—bone cancer	0.000371	0.00286	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—bone cancer	0.000369	0.00284	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Epirubicin—bone cancer	0.000369	0.00284	CcSEcCtD
Brinzolamide—Epistaxis—Epirubicin—bone cancer	0.000368	0.00283	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—bone cancer	0.000366	0.00282	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—bone cancer	0.000366	0.00282	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—bone cancer	0.000361	0.00278	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—bone cancer	0.000361	0.00278	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—bone cancer	0.00036	0.00277	CcSEcCtD
Brinzolamide—Hypersensitivity—Cisplatin—bone cancer	0.000357	0.00275	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—bone cancer	0.000356	0.00274	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—bone cancer	0.000351	0.0027	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—bone cancer	0.00035	0.0027	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—bone cancer	0.000349	0.00269	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—bone cancer	0.000349	0.00268	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—bone cancer	0.000348	0.00268	CcSEcCtD
Brinzolamide—Asthenia—Cisplatin—bone cancer	0.000347	0.00267	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—bone cancer	0.000347	0.00267	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—bone cancer	0.000347	0.00267	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—bone cancer	0.000345	0.00266	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—bone cancer	0.000345	0.00265	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—bone cancer	0.000344	0.00265	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—bone cancer	0.000343	0.00264	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—bone cancer	0.000341	0.00263	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—bone cancer	0.00034	0.00262	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—bone cancer	0.000339	0.00261	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—bone cancer	0.000338	0.0026	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—bone cancer	0.000338	0.0026	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—bone cancer	0.000337	0.0026	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—bone cancer	0.000337	0.00259	CcSEcCtD
Brinzolamide—Diarrhoea—Cisplatin—bone cancer	0.000331	0.00255	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—bone cancer	0.00033	0.00254	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—bone cancer	0.00033	0.00254	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—bone cancer	0.000328	0.00252	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—bone cancer	0.000327	0.00252	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—bone cancer	0.000326	0.00251	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—bone cancer	0.000325	0.00251	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—bone cancer	0.000325	0.00251	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—bone cancer	0.000325	0.0025	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—bone cancer	0.000325	0.0025	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—bone cancer	0.000322	0.00248	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—bone cancer	0.000321	0.00247	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—bone cancer	0.00032	0.00246	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—bone cancer	0.000319	0.00246	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—bone cancer	0.000319	0.00245	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—bone cancer	0.000318	0.00245	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—bone cancer	0.000317	0.00244	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—bone cancer	0.000317	0.00244	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—bone cancer	0.000316	0.00243	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—bone cancer	0.000315	0.00243	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—bone cancer	0.000315	0.00242	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—bone cancer	0.000313	0.00241	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—bone cancer	0.000312	0.0024	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—bone cancer	0.000309	0.00238	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—bone cancer	0.000308	0.00237	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—bone cancer	0.000307	0.00236	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—bone cancer	0.000306	0.00236	CcSEcCtD
Brinzolamide—Rash—Cisplatin—bone cancer	0.000305	0.00235	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—bone cancer	0.000305	0.00235	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—bone cancer	0.000305	0.00235	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—bone cancer	0.000305	0.00235	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—bone cancer	0.000303	0.00233	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—bone cancer	0.000302	0.00233	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—bone cancer	0.000302	0.00232	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—bone cancer	0.0003	0.00231	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—bone cancer	0.0003	0.00231	CcSEcCtD
Brinzolamide—Tension—Epirubicin—bone cancer	0.000299	0.0023	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—bone cancer	0.000298	0.0023	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—bone cancer	0.000296	0.00228	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—bone cancer	0.000295	0.00227	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—bone cancer	0.000294	0.00226	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—bone cancer	0.000293	0.00226	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—bone cancer	0.000293	0.00225	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—bone cancer	0.000292	0.00225	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—bone cancer	0.000292	0.00225	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—bone cancer	0.000292	0.00225	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—bone cancer	0.000289	0.00223	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—bone cancer	0.000287	0.00221	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—bone cancer	0.000287	0.00221	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—bone cancer	0.000286	0.0022	CcSEcCtD
Brinzolamide—Cough—Methotrexate—bone cancer	0.000284	0.00219	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—bone cancer	0.000284	0.00218	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—bone cancer	0.000283	0.00218	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—bone cancer	0.000282	0.00217	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—bone cancer	0.000282	0.00217	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—bone cancer	0.00028	0.00216	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—bone cancer	0.000278	0.00214	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—bone cancer	0.000277	0.00213	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—bone cancer	0.000277	0.00213	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—bone cancer	0.000277	0.00213	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—bone cancer	0.000277	0.00213	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—bone cancer	0.000276	0.00212	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000275	0.00212	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—bone cancer	0.000275	0.00211	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—bone cancer	0.000274	0.00211	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—bone cancer	0.000274	0.00211	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—bone cancer	0.000274	0.00211	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—bone cancer	0.000273	0.0021	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—bone cancer	0.000271	0.00209	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—bone cancer	0.000269	0.00207	CcSEcCtD
Brinzolamide—Cough—Epirubicin—bone cancer	0.000266	0.00205	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—bone cancer	0.000266	0.00204	CcSEcCtD
Brinzolamide—Infection—Methotrexate—bone cancer	0.000264	0.00203	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—bone cancer	0.000263	0.00202	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—bone cancer	0.000261	0.00201	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—bone cancer	0.00026	0.00201	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—bone cancer	0.000259	0.002	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—bone cancer	0.000259	0.002	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—bone cancer	0.000259	0.002	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—bone cancer	0.000259	0.00199	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—bone cancer	0.000258	0.00199	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000257	0.00198	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—bone cancer	0.000256	0.00197	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—bone cancer	0.000254	0.00196	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—bone cancer	0.000254	0.00195	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—bone cancer	0.000253	0.00195	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—bone cancer	0.000249	0.00192	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—bone cancer	0.000248	0.00191	CcSEcCtD
Brinzolamide—Infection—Epirubicin—bone cancer	0.000247	0.0019	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—bone cancer	0.000246	0.00189	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—bone cancer	0.000244	0.00188	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—bone cancer	0.000243	0.00187	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—bone cancer	0.000243	0.00187	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000242	0.00186	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—bone cancer	0.000241	0.00186	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—bone cancer	0.00024	0.00185	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—bone cancer	0.00024	0.00185	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—bone cancer	0.00024	0.00185	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—bone cancer	0.00024	0.00185	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—bone cancer	0.000238	0.00184	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000238	0.00183	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—bone cancer	0.000237	0.00183	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—bone cancer	0.000237	0.00182	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—bone cancer	0.000236	0.00182	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—bone cancer	0.000235	0.00181	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—bone cancer	0.000234	0.0018	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—bone cancer	0.000232	0.00179	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—bone cancer	0.000231	0.00178	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000229	0.00177	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—bone cancer	0.000229	0.00176	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—bone cancer	0.000228	0.00176	CcSEcCtD
Brinzolamide—Pain—Methotrexate—bone cancer	0.000227	0.00175	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000226	0.00174	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—bone cancer	0.000226	0.00174	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—bone cancer	0.000225	0.00173	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—bone cancer	0.000224	0.00173	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—bone cancer	0.000223	0.00172	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—bone cancer	0.000223	0.00172	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—bone cancer	0.000222	0.00171	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—bone cancer	0.000221	0.0017	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—bone cancer	0.000219	0.00169	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—bone cancer	0.000219	0.00168	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—bone cancer	0.000216	0.00166	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—bone cancer	0.000215	0.00165	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000215	0.00165	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—bone cancer	0.000214	0.00165	CcSEcCtD
Brinzolamide—Pain—Epirubicin—bone cancer	0.000213	0.00164	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—bone cancer	0.000211	0.00162	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00021	0.00161	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—bone cancer	0.000208	0.0016	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—bone cancer	0.000207	0.00159	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—bone cancer	0.000205	0.00158	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—bone cancer	0.000205	0.00158	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—bone cancer	0.000204	0.00157	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—bone cancer	0.000202	0.00156	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—bone cancer	0.0002	0.00154	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000199	0.00153	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—bone cancer	0.000198	0.00153	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—bone cancer	0.000197	0.00152	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—bone cancer	0.000197	0.00151	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—bone cancer	0.000196	0.00151	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—bone cancer	0.000191	0.00147	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—bone cancer	0.00019	0.00146	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—bone cancer	0.000188	0.00145	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—bone cancer	0.000183	0.00141	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—bone cancer	0.000183	0.00141	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—bone cancer	0.000182	0.0014	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—bone cancer	0.000178	0.00137	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—bone cancer	0.000176	0.00135	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—bone cancer	0.000176	0.00135	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—bone cancer	0.00017	0.00131	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—bone cancer	0.000169	0.0013	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—bone cancer	0.000169	0.0013	CcSEcCtD
Brinzolamide—Rash—Methotrexate—bone cancer	0.000167	0.00129	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—bone cancer	0.000167	0.00129	CcSEcCtD
Brinzolamide—Headache—Methotrexate—bone cancer	0.000166	0.00128	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—bone cancer	0.000165	0.00127	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—bone cancer	0.000164	0.00127	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—bone cancer	0.000163	0.00125	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—bone cancer	0.000158	0.00122	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—bone cancer	0.000158	0.00121	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—bone cancer	0.000157	0.00121	CcSEcCtD
Brinzolamide—Rash—Epirubicin—bone cancer	0.000157	0.00121	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—bone cancer	0.000157	0.00121	CcSEcCtD
Brinzolamide—Headache—Epirubicin—bone cancer	0.000156	0.0012	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—bone cancer	0.000152	0.00117	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—bone cancer	0.000148	0.00114	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—bone cancer	0.000146	0.00113	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—bone cancer	0.000145	0.00112	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—bone cancer	0.000145	0.00112	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—bone cancer	0.000144	0.00111	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—bone cancer	0.000137	0.00105	CcSEcCtD
